Haladyj E - Search Results

1

Variations in the interferon and TLR3 genes may be associated with susceptibility to systemic lupus erythematosus and its clinical presentation.

Modzelewska E, Wajda A, Lutkowska A, Felis-Giemza A, Stypińska B, Matusiewicz A, Puszczewicz M, Majewski D, Jagodziński PP, Haładyj E, Paradowska-Gorycka A. Modzelewska E, et al. Among authors: haladyj e. Immunobiology. 2024 May 2:152807. doi: 10.1016/j.imbio.2024.152807. Online ahead of print. Immunobiology. 2024. PMID: 38821752 Free article.

2

Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset.

Ciciriello S, Littlejohn GO, Treuer T, Gibson KA, Haladyj E, Youssef P, Bird P, O'Sullivan C, Smith T, Deakin CT. Ciciriello S, et al. Among authors: haladyj e. Clin Exp Rheumatol. 2024 May 1. doi: 10.55563/clinexprheumatol/n0kjax. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 38757292

3

Efficacy Of Baricitinib in Patients With Moderate-To-Severe Rheumatoid Arthritis Up to 6.5 Years Of Treatment: Results Of A Long-Term Study.

Caporali R, Taylor PC, Aletaha D, Sanmartí R, Takeuchi T, Mo D, Haladyj E, Bello N, Zaremba-Pechmann L, Fang Y, Dougados M. Caporali R, et al. Among authors: haladyj e. Rheumatology (Oxford). 2024 Jan 22:keae012. doi: 10.1093/rheumatology/keae012. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38258434

4

Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis.

Hernández-Cruz B, Kiltz U, Avouac J, Treuer T, Haladyj E, Gerwien J, Gupta CD, Conti F. Hernández-Cruz B, et al. Among authors: haladyj e. Rheumatol Ther. 2023 Dec;10(6):1417-1457. doi: 10.1007/s40744-023-00591-9. Epub 2023 Sep 16. Rheumatol Ther. 2023. PMID: 37715917 Free PMC article. Review.

5

Pregnancy outcomes in patients exposed to baricitinib in clinical trials and during postmarketing surveillance.

Bergamini B, Seneschal J, Meyers KJ, Durand F, Haladyj E, Espinosa G, Thyssen JP. Bergamini B, et al. Among authors: haladyj e. Br J Dermatol. 2023 Nov 16;189(6):767-769. doi: 10.1093/bjd/ljad279. Br J Dermatol. 2023. PMID: 37595142 No abstract available.

6

A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib Experience.

Taylor PC, Laedermann C, Alten R, Feist E, Choy E, Haladyj E, De La Torre I, Richette P, Finckh A, Tanaka Y. Taylor PC, et al. Among authors: haladyj e. J Clin Med. 2023 Jul 6;12(13):4527. doi: 10.3390/jcm12134527. J Clin Med. 2023. PMID: 37445562 Free PMC article. Review.

7

Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.

Bieber T, Feist E, Irvine AD, Harigai M, Haladyj E, Ball S, Deberdt W, Issa M, Grond S, Taylor PC. Bieber T, et al. Among authors: haladyj e. Adv Ther. 2023 Sep;40(9):4114-4115. doi: 10.1007/s12325-023-02526-w. Epub 2023 Jun 22. Adv Ther. 2023. PMID: 37347406 Free PMC article. No abstract available.

8

Comparative Effectiveness of First-Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set.

Ciciriello S, Littlejohn G, Treuer T, Gibson KA, Haladyj E, Youssef P, Bird P, O'Sullivan C, Smith T, Deakin CT; OPAL Rheumatology. Ciciriello S, et al. Among authors: haladyj e. ACR Open Rheumatol. 2023 Jul;5(7):345-353. doi: 10.1002/acr2.11577. Epub 2023 Jun 12. ACR Open Rheumatol. 2023. PMID: 37308464 Free PMC article.

9

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications.

Taylor PC, Bieber T, Alten R, Witte T, Galloway J, Deberdt W, Issa M, Haladyj E, De La Torre I, Grond S, Wollenberg A. Taylor PC, et al. Among authors: haladyj e. Adv Ther. 2023 Apr;40(4):1867-1883. doi: 10.1007/s12325-023-02445-w. Epub 2023 Feb 20. Adv Ther. 2023. PMID: 36802049 Free PMC article. Clinical Trial.

10

Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical Trials.

Fautrel B, Wu J, Wang D, Haladyj E, van de Laar MAFJ, Takeuchi T. Fautrel B, et al. Among authors: haladyj e. J Clin Rheumatol. 2023 Apr 1;29(3):139-144. doi: 10.1097/RHU.0000000000001924. Epub 2022 Dec 7. J Clin Rheumatol. 2023. PMID: 36473106 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page